By Nigam Arora & Dr. Natasha Arora
Signal Limited is a Signal(s) with a great record in similar situations but does not meet all of the stringent criteria for a Signal. Typically Signal Limited has higher risk-reward compared to a Signal over the short term.
Congratulations! TV maker Vizio (VZIO) has agreed to be bought out by Walmart (WMT).
VZIO has become the 191st Arora Report portfolio company to be bought out. Buyouts are very lucrative for investors. Long time members of The Arora Report have made a fortune from buyouts. With 191 buyouts, the performance of The Arora Report is significantly better than firms charging upwards of $50,000 per year. With The Arora Report, you get so much more than buyouts.
The buyout price is $11.50 per share in cash.
There is a provision in the agreement that allows VZIO to back out of the deal if it gets a superior offer.
What To Do Now
It’s a matter of personal preference to take profits now or to wait. Since there is a small probability of a higher offer, those who are willing to take some risk may consider continuing to hold.
For some investors a good option is to take partial profits and hold the rest.
To take a free 30-day trial to paid services to gain access to more opportunities, please click here.
This post was just published on ZYX Buy Change Alert.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE
TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.
